Inogen, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Loss per Share (Tables)

Loss per Share (Tables)

3 Months Ended

Mar. 31, 2026

The computation of EPS is as follows:


	Three months ended March 31,
	2026			2025
Numerator—basic and diluted:
Net loss	$	(8,324	)	$	(6,174	)

Denominator:
Weighted average shares of common stock - basic common stock (1)		27,322,438			25,164,444
Weighted average shares of common stock - diluted common stock		27,322,438			25,164,444

Net loss per share - basic common stock	$	(0.30	)	$	(0.25	)
Net loss per share - diluted common stock (2)	$	(0.30	)	$	(0.25	)

Denominator calculation from basic to diluted:
Weighted average shares of common stock - basic common stock (1)		27,322,438			25,164,444
Other dilutive awards		445,213			684,657
Weighted average shares of common stock - diluted common stock		27,767,651			25,849,101

Shares excluded from diluted weighted average shares:
Restricted stock units		1,222,296			495,777

(1) Unvested restricted stock units are not included as shares outstanding in the calculation of basic earnings per share. Vested restricted stock units are included in basic earnings per share if all vesting and performance criteria have been met. Performance-based restricted stock units are included in the number of shares used to calculate diluted earnings per share as long as all applicable performance criteria are met, and their effect is dilutive.

(2) Due to net losses for the three months ended March 31, 2026 and March 31, 2025, diluted loss per share is the same as basic loss per share.